At GIG, Tong has worked in equity investment for over 15 years, and formed deep understanding of the intrinsic value and potential of growth companies. She has acquired an expert perspective on the healthcare industry from her experience as board member of numerous pharmaceutical/biotech companies, and a strong background in risk management and M&A from her experience as Assistant Managing Director at M&A Division of GUOTAI JUNAN Securities, a first-tier investment bank in China.
Tong currently serves as a board member of AkesoBio，Mab-works, Beijing Biohealthcare Biotechnology, Hainan Tianhuang Pharmacy co.ltd and Huiyinbi Pharm Group. Her investment portfolio also includes Mindray Medical (former NYSE:MR), Jiangxi Lcetron electronics （002036.SZ），Jiangsu Lingbao Pharmaceutical co.ltd，Jiangsu Chenpai Pharmaceutical Group and Jiangsu Vanguard Pharmaceutical co.ltd.
Tong holds an EMBA degree in CEIBS, and received her MS and BS degree in Accounting.